The Food and Drug Administration has approved Zoryve (roflumilast) topical foam, 0.3% for plaque psoriasis of the scalp and body.

Physical activity levels have a significant association with a reduced incidence of restrictive spirometry patterns (RSP).

The FDA has approved Starjemza (ustekinumab-hmny), a biosimilar to Stelara (ustekinumab), for the treatment of various chronic inflammatory diseases.

Male athletes with high-volume exercise training have a higher burden of calcified plaque than male nonathletes.

Metformin was associated with significantly reduced knee pain among patients with overweight/obesity and knee osteoarthritis.

Dry eye disease metrics, such as NIBUT and MG dropout, may serve as predictive biomarkers for possible thyroid disorders.

The global age-standardized incidence and prevalence rates of RA increased from 1990 to 2021 while mortality rates declined.

A federal deadline ending the sale of off-brand weight-loss and diabetes medications is now in effect, cutting off access to drugs many patients count on.

Neuraxial anesthesia is associated with significantly reduced odds of several major postoperative complications in patients undergoing hip fracture procedures, according to resear ...

Research findings increasingly indicate close associations between autoimmune thyroid disease and rheumatic disease.

Weight loss treatment combining personalized semaglutide with intensive behavioral therapy (IBT) yields weight loss similar to that reported in confirmatory trials, with a lower dose of medication.

Sedentary behavior among US adults fell between 2013 and 2020 but plateaued after that, according to a research letter.